Details for New Drug Application (NDA): 070032
✉ Email this page to a colleague
NDA 070032 describes SULFAMETHOPRIM-DS, which is a drug marketed by Novel Labs Inc and is included in one NDA. Additional details are available on the SULFAMETHOPRIM-DS profile page.
The generic ingredient in SULFAMETHOPRIM-DS is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
The generic ingredient in SULFAMETHOPRIM-DS is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
Summary for 070032
| Tradename: | SULFAMETHOPRIM-DS |
| Applicant: | Novel Labs Inc |
| Ingredient: | sulfamethoxazole; trimethoprim |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 800MG;160MG | ||||
| Approval Date: | Feb 15, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
